About Us

Corporate Governance

CliniWater operates as an independent brand with complete ownership of its technology, quality systems, and clinical partnerships. Governance is not a bureaucratic formality—it is the disciplined framework that ensures every strategic decision, from product specification to regulatory submission, serves one fixed and immutable reference point: water quality safety in healthcare settings.

Since inception, we have maintained a lean but rigorous governance structure. Shareholders appoint a Board of Directors responsible for strategic oversight. The Board integrates expertise in nephrology, laboratory medicine, infection control, biomedical engineering, water chemistry, and global regulatory affairs—ensuring that product decisions are grounded in clinical reality rather than commercial convenience. Specialized committees operate within the Board in proportion to the company’s scale:

  • Audit Committee – oversees financial reporting, internal controls, and external audits. Financial integrity underpins clinical integrity.
  • Nomination Committee – ensures the right balance of clinical, technical, and environmental expertise on the Board, identifying members who understand the unique pressures of healthcare water management.
  • Compensation Committee – aligns executive rewards with long-term value creation, measured by system uptime, clinical satisfaction, and documented improvements in water quality outcomes.

The Board appoints executive officers to execute the strategic vision. Supporting them are internal groups, including a Water Quality and Technology Committee, which reviews system performance, sensor accuracy, calibration drift, and adverse event reports, and a Risk and Regulatory Panel, which manages regulatory changes, supplier audits, and field safety corrections. An independent Internal Audit team reports directly to the Audit Committee.

Based in China, with partners and clients across global markets, CliniWater applies these governance principles across all operations. A lean structure does not weaken governance; it makes every decision visible, every risk owned, and every leader accessible. Governance is not a diagram—it is a commitment to the dialysis patient waiting for treatment, the laboratory technician preparing a critical sample, the CSSD staff sterilizing surgical instruments, the endoscopy nurse reprocessing a flexible scope, the dental hygienist maintaining waterline cleanliness, and the facility manager who must balance operational budgets against water quality requirements.

The Board of Directors

CliniWater is led by its founders and an executive team, with strategy reviewed by a Board of Directors. The Board ensures that long-term plans for products, technology, and market expansion remain aligned with core values and water quality safety. It delegates oversight to the Water Quality and Technology Committee, which meets quarterly and reports to the full Board. This structure ensures that quality and safety remain above commercial pressure—especially in a field where water quality failures can have cascading clinical consequences.

Governance Principles

Three anchors guide all decisions: transparency, accountability, and an unwavering focus on water quality safety. Design reviews, supplier selections, field corrections, and post-market surveillance are meticulously documented and traceable. Accountability extends to every clinician, technician, and facility manager who relies on our water treatment systems, monitoring instruments, and consumables.

Risk Management and Compliance

CliniWater operates under a certified quality management system conforming to ISO 13485 and relevant water quality standards. Risk management follows ISO 14971 with heightened attention to water-related hazards: microbial contamination, endotoxin breakthrough, chemical contaminant ingress, biofilm formation, system failure during critical procedures, and environmental discharge non-compliance. Registrations in China, the European Union, and other jurisdictions are maintained directly by CliniWater. Regulatory changes are continuously monitored and incorporated.

Because we control our technology and supply chain, we also control supplier qualification. Our supplier audit programme includes annual on-site assessments focusing on ISO 13485, water quality standards, and specific healthcare-water requirements. No component enters a CliniWater system without internal verification.

Stakeholder Engagement

We work closely with nephrologists, laboratorians, infection control officers, CSSD managers, endoscopy nurses, dental clinicians, biomedical engineers, facility managers, environmental compliance officers, distributors, regulators, employees, and manufacturing partners. Engagement includes clinical advisory panels, post-installation satisfaction surveys, open channels for near-miss reporting, and regular design-review forums with factory partners. We are a responsive team—we listen because listening directly translates to safer water for patients.

Communications from CliniWater

Subscribe to CliniWater to unlock integrated water treatment solutions across dialysis, laboratory, CSSD, endoscopy, and dental care—elevating water purity, infection control, and clinical compliance through a unified ecosystem of treatment, monitoring, and disinfection platforms.